Invention Grant
- Patent Title: Sulfated-glycolipids as adjuvants for vaccines
-
Application No.: US15325640Application Date: 2015-07-10
-
Publication No.: US10647737B2Publication Date: 2020-05-12
- Inventor: Dennis M. Whitfield , G. Dennis Sprott , Lakshmi Krishnan
- Applicant: National Research Council of Canada
- Applicant Address: CA Ottawa, Ontario
- Assignee: National Research Council of Canada
- Current Assignee: National Research Council of Canada
- Current Assignee Address: CA Ottawa, Ontario
- International Application: PCT/CA2015/000430 WO 20150710
- International Announcement: WO2016/004512 WO 20160114
- Main IPC: C07H15/04
- IPC: C07H15/04 ; A61K39/00 ; A61K39/39

Abstract:
A synthetic charged glycolipid is described comprising a sulfated saccharide group covalently linked to the tree sn-1 hydroxyl group of the glycerol backbone of an archaeal core lipid via a beta linkage. The synthetic charged glycolipids include compounds of formula I wherein n is 0 or 1; R is hydrogen or hydroxyl; and Y is hydrogen or a sulfate group, at least one Y being a sulfate group; and including pharmaceutically acceptable salts thereof. The sulfated glycolipid produces stable archaeosomes at a mol % ratio of from 100:0 to 30:70 (sulfated glycolipid:uncharged glycolipid) and which induce a protective immune response, including CD8+ and CD4+ T cell responses. Archaeosomes comprising the sulfated glycolipids described have desirable adjuvant properties, particularly when mixed with uncharged glycolipid at a mol % ratio of about 50:50.
Public/Granted literature
- US20170158728A1 SULFATED-GLYCOLIPIDS AS ADJUVANTS FOR VACCINES Public/Granted day:2017-06-08
Information query
IPC分类: